Resoundant, Inc. to Exhibit at RSNA 2017
Company announces issuance of new CPT® code for standalone MRE exam.
Rochester, MN, USA,—Resoundant, Inc., the developer of Magnetic Resonance Elastography (MRE), is pleased to offer information and resources on MRE for liver disease staging to attendees of the Radiological Society of North America (RSNA) Annual Meeting at McCormick Place, Chicago, November 26—December 1. Resoundant, Inc. will be exhibiting at Booth #6547, where attendees can learn more about how MRE can benefit their patients and practices. In dozens of clinical studies reported throughout the years, MRE has been shown to have the highest clinical accuracy for staging liver fibrosis. MRE’s unrivaled diagnostic capability and high applicability for nearly all patients will continue to be critical for staging of liver fibrosis, particularly among patients with fatty liver disease – a condition that affects nearly 30% of the population.
Attendees are also invited to attend a Lunch & Learn session on Monday, November 27, to learn more about MRE in clinical practice. Those in attendance will hear from internationally recognized leaders on the current use and future of MRE for liver disease assessment. Lunch will also be provided free of charge, courtesy of Resoundant. Those interested in attending can learn more or register at: www.resoundant.com/lunchandlearn.
Resoundant, Inc. is also pleased to announce that the American Medical Association (AMA) has assigned a new, discrete Category I CPT® (Current Procedural Technology) code to facilitate reimbursement for MRE applications during its October panel meeting.
“The definition of a standalone code is a major milestone towards the affirmation of MRE as a valuable medical technology and new standard of care for liver fibrosis staging across the U.S.,” said Troy Ziegler, Chief Operating Officer at Resoundant.
Obtaining Category I CPT® code can only be achieved once there is sufficient evidence demonstrating that the procedure can improve patient outcomes, has support of the professional medical societies, is recognized in practice guidelines and enjoys widespread clinical adoption.
“In many ways, the issuance of a Category I CPT® code makes MRE the poster child for value in Radiology,” said Ziegler. “Referring clinicians will now have standalone access to the elastography portion of an abdominal MR workup when desired, at a significantly lower systemic cost. And with significantly less scan time required per MRE exam, Radiology practices will have the opportunity increase patient throughput when compared to providing a full abdominal workup.”
Both the AASLD and the American Gastroenterological Association released updated practice guidelines in 2017 that included recommendations for the use of MRE for liver fibrosis staging. The American College of Radiology also issued Appropriateness Criteria® that identifies MRE as the most accurate and applicable noninvasive liver fibrosis test.
MR Elastography remains widely available to clinicians at over 800 Radiology and imaging centers across the globe. Clinicians and patients can find U.S. locations at MRE:connect (www.resoundant.com/mre-connect).
To learn how MRE can help their practice, attendees can go to www.resoundant.com/for-providers or stop by the new Resoundant booth (Booth #6547) at the RSNA conference.
About the AMA CPT® System
The CPT® coding system offers doctors across the country a uniform process for coding medical services that streamlines reporting and increases accuracy and efficiency. For more than 4 decades, physicians and other health care professionals have relied on CPT to communicate with colleagues, patients, hospitals and insurers about the procedures they have performed.
CPT descriptive terms and identifying codes currently serve a wide variety of important functions. This system of terminology is the most widely accepted medical nomenclature used to report medical procedures and services under public and private health insurance programs. CPT is also used for administrative management purposes such as claims processing and developing guidelines for medical care review.
The uniform language is also applicable to medical education and research by providing a useful basis for local, regional and national utilization comparisons.
About Resoundant, Inc.
Resoundant, Inc. is a medical technology company dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance Elastography (MRE) available around the world. Resoundant is based in Rochester, MN and was founded by Mayo Foundation for Medical Education & Research, Mayo Clinic physicians and researchers.
For more information, go to http://www.resoundant.com
Chief Operating Officer
Sales & Channel Partnerships